Table 1 Clinical data of control subjects and patients with CAD, VA, or NVA (% and mean ± SD, ANOVA test)

Age, years

54.8 ± 7.5

59.9 ± 8.9

54.5 ± 9.7

55.5 ± 9.1

0.412

Female gender, %

50

40

20

52.2

0.233

Arterial hypertension, %

0

40

53.3

56.5

0.001

Diabetes mellitus, %

0

20

0

0

0.020

Smoking, %

0

40

46.7

26

0.001

Total cholesterol, mg/dl

204 ± 31

234 ± 37

225 ± 38

223 ± 37

0.127

   LDL, mg/dl

126 ± 28

158 ± 24

147 ± 23

139 ± 32

0.031

   HDL, mg/dl

56 ± 12

46 ± 11

57 ± 16

56 ± 16

0.270

Triglycerides, mg/dl

108 ± 61

169 ± 95

107 ± 33

157 ± 112

0.107

Ejection fraction, %

--

55.7 ± 5.5

74.6 ± 4.4

74.1 ± 5.2

0.001

Treatment: (%)

   Nitrates

0

0

60

47.8

0.006

   Beta blockers

0

70

6.7

26.1

0.003

   Calcium channel blockers

0

20

86.7

56.5

0.004

   ACE inhibitors

0

40.7

26.7

21.7

0.581

   Aspirin

0

100

40

21.7

0.001

   Statins

0

60

13.3

26.1

0.049